ProMIS Neurosciences
PMN
27 hedge funds and large institutions have $84.3M invested in ProMIS Neurosciences in 2026 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 2 closing their positions.
150% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 2
8% more funds holding
Funds holding: 25 → 27 (+2)
8% more capital invested
Capital invested by funds: $78M → $84.3M (+$6.24M)
2.89% more ownership
Funds ownership: 68.5% → 71.39% (+2.9%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ABG
Ally Bridge Group
New York
|
+$2.24M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
+$2.02M |
| 3 |
IC
Ikarian Capital
Dallas,
Texas
|
+$1.63M |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
+$506K |
| 5 |
BFM
Boothbay Fund Management
New York
|
+$500K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$3.1M |
| 2 |
EAM
Empery Asset Management
New York
|
-$766K |
| 3 |
HCM
Heights Capital Management
San Francisco,
California
|
-$643K |
| 4 |
Millennium Management
New York
|
-$237K |
| 5 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
-$27.1K |
PMN Hedge Fund Activity: Q2 2026 in Review
27 of the 8,318 institutional investors tracked by Wall St. Rank reported a position in ProMIS Neurosciences (PMN) for Q2 2026, worth a combined $84.3M — up 8% from $78M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new PMN positions and 2 closed out — a net gain of 3 holders — while 6 added to existing stakes and 6 trimmed.
The largest buyer was Ally Bridge Group, adding an estimated $2.24M. The largest seller was Great Point Partners, cutting an estimated $3.1M.
- 27 institutional investors held ProMIS Neurosciences (PMN) as of Q2 2026, up from 25 in Q1 2026.
- Funds reported $84.3M of ProMIS Neurosciences stock for Q2 2026, up 8% quarter-over-quarter.
- 5 funds opened new ProMIS Neurosciences positions in Q2 2026 and 2 closed out, a net change of +3 holders.
- The largest ProMIS Neurosciences buyer in Q2 2026 was Ally Bridge Group, an estimated $2.24M added.
- The largest ProMIS Neurosciences seller in Q2 2026 was Great Point Partners, an estimated $3.1M sold.
Based on aggregated 13F filings for Q2 2026.